Cargando…

Salvianolic Acid B Down-regulates Matrix Metalloproteinase-9 Activity and Expression in Tumor Necrosis Factor-α-induced Human Coronary Artery Endothelial Cells

BACKGROUND: Salvianolic acid B (Sal B) is a bioactive water-soluble compound of Salviae miltiorrhizae, a traditional herbal medicine that has been used clinically for the treatment of cardiovascular diseases. This study sought to evaluate the effect of Sal B on matrix metalloproteinase-9 (MMP-9) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Le, Guan, Yun-Qian, Du, Zhong-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736853/ https://www.ncbi.nlm.nih.gov/pubmed/26415806 http://dx.doi.org/10.4103/0366-6999.166037

Ejemplares similares

Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling
por: Jiang, Baohong, et al.
Publicado: (2010)

Salvianolic Acid A, a Novel Matrix Metalloproteinase-9 Inhibitor, Prevents Cardiac Remodeling in Spontaneously Hypertensive Rats
por: Jiang, Baohong, et al.
Publicado: (2013)

Matrix metalloproteinases in coronary artery disease and myocardial infarction
por: Bräuninger, Hanna, et al.
Publicado: (2023)

Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells
por: Xiang, Jie, et al.
Publicado: (2022)

Rhubarb Antagonizes Matrix Metalloproteinase-9-induced Vascular Endothelial Permeability
por: Cui, Yun-Liang, et al.
Publicado: (2016)

Association of Matrix Metalloproteinases with Coronary Artery Calcification in Patients with CHD
por: Polonskaya, Yana V., et al.
Publicado: (2021)

Correlation between genetic polymorphism of matrix metalloproteinase-9 in patients with coronary artery disease and cardiac remodeling
por: Yu, Qibin, et al.
Publicado: (2015)

Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells
por: Ianni, Andrea, et al.
Publicado: (2022)

Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-α in Chronic Hepatitis C Virus Patients
por: Abdel-Latif, Mohamed S
Publicado: (2015)

Interferon-Gamma Increases the Ratio of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 in Peripheral Monocytes from Patients with Coronary Artery Disease
por: Springall, Rashidi, et al.
Publicado: (2013)

Pamidronate Down-regulates Tumor Necrosis Factor-alpha Induced Matrix Metalloproteinases Expression in Human Intervertebral Disc Cells
por: Kang, Young-Mi, et al.
Publicado: (2016)

Expression of Toll-Like Receptor 4, Tumor Necrosis Factor- Alpha, Matrix Metalloproteinase-9 and Effects of Benazepril in Patients with Acute Coronary Syndromes
por: Xie, Ping, et al.
Publicado: (2010)

Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease
por: Mahmoodi, Khalil, et al.
Publicado: (2017)

Correlation Between Matrix Metalloproteinases With Coronary Artery Lesion Caused by Kawasaki Disease
por: Tian, Fang, et al.
Publicado: (2022)

Effects of resveratrol and genistein on nuclear factor-κB, tumor necrosis factor-α and matrix metalloproteinase-9 in patients with chronic obstructive pulmonary disease
por: LIU, XIAO-JU, et al.
Publicado: (2016)

Mangiferin inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 expression and cellular invasion by suppressing nuclear factor-κB activity
por: Dilshara, Matharage Gayani, et al.
Publicado: (2015)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Puerarin Attenuated Early Diabetic Kidney Injury through Down-Regulation of Matrix Metalloproteinase 9 in Streptozotocin-Induced Diabetic Rats
por: Zhong, Yifei, et al.
Publicado: (2014)

Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease
por: Dong, Pengxin, et al.
Publicado: (2018)

Matrix metalloproteinase-9 predicts pulmonary status declines in α(1)-antitrypsin deficiency
por: Omachi, Theodore A, et al.
Publicado: (2011)

Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9
por: Reynolds, SL, et al.
Publicado: (2012)

Salivary and plasma levels of matrix metalloproteinase-9 and myeloperoxidase at rest and after acute physical exercise in patients with coronary artery disease
por: Mahmood, Zeid, et al.
Publicado: (2019)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

Expression of matrix metalloproteinases in bovine luteal cells induced by prostaglandin F2α, interferon γ and tumor necrosis factor α
por: ABE, Hironori, et al.
Publicado: (2015)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

DACH1 inhibits breast cancer cell invasion and metastasis by down-regulating the transcription of matrix metalloproteinase 9
por: Aman, Sattout, et al.
Publicado: (2021)

Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro
por: Takata, Fuyuko, et al.
Publicado: (2011)

Tumor Necrosis Factor-α, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects
por: Kuehl, Melanie N., et al.
Publicado: (2015)

Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and -9: An in vitro study
por: Gao, Hua, et al.
Publicado: (2011)

Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells
por: Zhao, Ye, et al.
Publicado: (2016)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease
por: Shimizu, Chisato, et al.
Publicado: (2010)

Matrix Metalloproteinase-2 Polymorphisms and Incident Coronary Artery Disease: A Meta-Analysis
por: Shi, Yujie, et al.
Publicado: (2015)

Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease
por: Samah, Nazirah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_msjbkrt6t2qr7vuuukg1q4adpl